Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Japan Microbiome Diagnostics Market, by Application
1.4.2 Japan Microbiome Diagnostics Market, by Product
1.4.3 Japan Microbiome Diagnostics Market, by Sample
1.4.4 Japan Microbiome Diagnostics Market, by Technology
1.4.5 Japan Microbiome Diagnostics Market, by End User
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Opportunities
2.2.3 Market Restraints
2.2.4 Market Challenges
2.2.5 Market Trends
2.3 Porter Five Forces Analysis
Chapter 3. Strategies Deployed in Microbiome Diagnostics Market
Chapter 4. Japan Microbiome Diagnostics Market
4.1 Japan Microbiome Diagnostics Market by Application
4.1.1 Japan Microbiome Diagnostics Market by Disease Diagnostics Type
4.2 Japan Microbiome Diagnostics Market by Product
4.3 Japan Microbiome Diagnostics Market by Sample
4.4 Japan Microbiome Diagnostics Market by Technology
4.5 Japan Microbiome Diagnostics Market by End User
Chapter 5. Company Profiles – Global Leaders
5.1 Illumina, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.1.5 Recent strategies and developments:
5.1.5.1 Partnerships, Collaborations, and Agreements:
5.1.6 SWOT Analysis
5.2 Becton, Dickinson, and Company
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expense
5.2.5 Recent strategies and developments:
5.2.5.1 Product Launches and Product Expansions:
5.2.5.2 Trails and Approvals:
5.2.6 SWOT Analysis
5.3 Genetic Analysis AS
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.4 Microba Life Sciences Limited
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Regional Analysis
5.4.4 Research & Development Expenses
5.4.5 Recent strategies and developments:
5.4.5.1 Partnerships, Collaborations, and Agreements:
5.4.5.2 Product Launches and Product Expansions:
5.5 BioMe Oxford Ltd
5.5.1 Company Overview
5.5.2 Recent strategies and developments:
5.5.2.1 Partnerships, Collaborations, and Agreements:
5.6 Viome Life Sciences, Inc.
5.6.1 Company Overview
5.6.2 Recent strategies and developments:
5.6.2.1 Product Launches and Product Expansions:
5.6.2.2 Acquisition and Mergers:
5.7 GoodGut S.L.U. (HIPRA, S.A.)
5.7.1 Company Overview
5.8 Sun Genomics
5.8.1 Company Overview
5.9 Origin Sciences Limited
5.9.1 Company Overview
5.10. Decode Age
5.10.1 Company Overview
Unique Offerings 